Manuscripts
Showing 1591 manuscripts.
Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.
Citation
Mary-Ann Davies, Kunjal Pate, M Koller, B Chi, K Wools-Kaloustian, V Leroy, K Chokephaibulkit, C Chimbetete, D Avila, R Hazra, S Ayaya, F Dicko, HK Trong, M Egger. Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries. Journal of Acquired Immune Deficiency Syndromes. 2015 Jan 01; 68(1):62-72. PMID: 25501345; PMCID: PMC4351302.Year
2015
Journal
Journal of Acquired Immune Deficiency Syndromes
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Citation
Alice Stek, Brookie M Best, Jiajia Wang, Edmund V Capparelli, Sandra K Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Tim R Cressey, Lynne M Mofenson, Elizabeth Smith, David Shapiro, Mark Mirochnick. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. Journal of Acquired Immune Deficiency Syndromes. 2015 Sep 01; 70(1):33-41. PMID: 25950206; PMCID: PMC4579345.Year
2015
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1
Citation
Grant R. Campbell, Rachel S. Bruckman, Stephen A. Spector. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. Journal of Biological Chemistry. 2015 Feb 20; 290(8):5028-5040. PMID: 25540204; PMCID: PMC4335239.Year
2015
Journal
Journal of Biological Chemistry
Resistance detected by pyrosequencing following zidovudine-monotherapy for
prevention of HIV-1 mother-to-child-transmission
Citation
SC Olson, N Nqo-Giang-Huong, I Beck, W Deng, P Britto, DE Shapiro, RE Bumgarner, JI Mullins, RB Van Dyke, G Jourdain, LM Frenkel. Resistance detected by pyrosequencing following zidovudine-monotherapy for prevention of HIV-1 mother-to-child-transmission. AIDS. 2015 Jul 31; 29(12):1467-1471. PMID: 26244386; PMCID: PMC4618483.Year
2015
Journal
AIDS
Study
P1032
Frequent Nevirapine Resistance in Infants Infected by HIV-1 via Breastfeeding while on Nevirapine Prophylaxis: Results of the BAN Study
Citation
JA Nelson, A Fokar, MG Hudgens, KJ Compliment, JT Hawkins, G Tegha, DD Kamwendo, D Kayira, IA Mofolo, AP Kourtis, DJ Jamieson, CM Van Der Horst, SA Fiscus. Frequent Nevirapine Resistance in Infants Infected by HIV-1 via Breastfeeding while on Nevirapine Prophylaxis: Results of the BAN Study. AIDS. 2015 Jul 17; PMID: 26186128.Year
2015
Journal
AIDS
Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women
Citation
Adriana Weinberg , Petronella Muresan, Kelly Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin for the P1086 study team. Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women. AIDS Research and Human Retroviruses. 2015 Nov 14; 31(11):1170-7. PMID: 26322930; PMCID: PMC4651022.Year
2015
Journal
AIDS Research and Human Retroviruses
Study
P1086
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth
Citation
DJ Curtis, P Muresan, S Nachman, T Fenton, KM Richardson, T Dominguez, PM Flynn, SA Spector, CK Cunningham, A Bloom, A Weinberg. Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth. PLoS One. 2015 Mar 18; 3:e0118567. PMID: 25785995; PMCID: PMC4364897.Year
2015
Journal
PLoS One
Study
P1088
Cost-effectiveness of first-line antiretroviral therapy for
HIV-infected African children less than three years of age
Citation
AL Ciaranello, K Doherty, M Penazzato, JC Lindsey, L Harrison, K Kelly, RP Walensky, S Essajee, E Losina, L Muhe, K Wools-Kaloustian, S Ayaya, MC Weinstein, P Palumbo, KA Freedberg. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than three years of age. AIDS. 2015 Jun 19; 29(10):1247-1259. PMID: 25870982; PMCID: PMC4536981.Year
2015
Journal
AIDS
Study
P1060
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093
Citation
Rolando M. Viani, Carmelita Alvero, Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen O’Gara, Debra Steimers, Sherene Min, Andrew Wiznia on behalf of the P1093 study team. Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093. Pediatric Infectious Disease Journal. 2015 Nov 11; 34(11):1207-1213. PMID: 26244832; PMCID: PMC4604048.Year
2015
Journal
Pediatric Infectious Disease Journal
Study
P1093